{"id":"W2129174532","doi":"10.1200/jco.2008.17.1249","title":"Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Irinotecan; Medicine; Oxaliplatin; Internal medicine; Colorectal cancer; Capecitabine; Oncology; Hazard ratio; Gastroenterology; Progression-free survival; FOLFIRINOX; Chemotherapy; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001094275,0.0006366082,0.001968879,0.000276259,0.0001524069,0.0005704345,0.0004464045,0.0005498252,0.001956557],"category_scores_gemma":[0.001200207,0.0002070549,0.0008779203,0.0002934663,0.0004338734,0.000482175,0.0002282338,0.001275003,0.0002204745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005177127,"about_ca_system_score_gemma":0.0006609308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004904879,"about_ca_topic_score_gemma":0.001681365,"domain_scores_codex":[0.9995387,0.0002493986,0.00003271201,0.000076011,0.00004491193,0.00005825076],"domain_scores_gemma":[0.9991479,0.0002413133,0.0002639034,0.00003108343,0.00002862879,0.0002871998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8306008,0.01536435,0.009398588,0.0009870444,0.001863318,0.0001019569,0.0001063717,0.001996948,0.02340595,0.00009846314,0.0007350336,0.1153413],"study_design_scores_gemma":[0.2083805,0.7449985,0.03440834,0.00008367498,0.001901133,0.0003711729,0.00005299956,0.002114174,0.006163041,0.00009914765,0.001400547,0.00002681874],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967639,0.002377544,0.0001064331,0.0001025104,0.00008779865,0.0001466367,0.00006188705,0.00001529707,0.0003378069],"genre_scores_gemma":[0.9976642,0.001160559,0.0003201012,0.0001374838,0.0001233244,0.0001119756,0.0001312864,0.000003484325,0.0003476632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001968879,"threshold_uncertainty_score":0.006545305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1910239028002175,"score_gpt":0.4228029072623538,"score_spread":0.2317790044621363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}